Evaluation of bone marrow aspirates in patients with acute myeloid leukemia at day 14 of induction therapy

被引:0
|
作者
João Tadeu D Souto Filho
Monique M Loureiro
Wolmar Pulcheri
José Carlos Morais
Marcio Nucci
Rodrigo D Portugal
机构
[1] University Hospital,
[2] Universidade Federal do Rio de Janeiro,undefined
[3] Faculdade de Medicina de Campos,undefined
[4] Instituto Federal de Educação,undefined
[5] Ciência e Tecnologia Fluminense,undefined
来源
关键词
Acute myeloid leukemia; Bone marrow; Blasts counting; D14;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Evaluation of bone marrow aspirates in patients with acute myeloid leukemia at day 14 of induction therapy
    Souto Filho, Joao Tadeu D.
    Loureiro, Monique M.
    Pulcheri, Wolmar
    Morais, Jose Carlos
    Nucci, Marcio
    Portugal, Rodrigo D.
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [2] Prognosis and Application of Day 14 Bone Marrow Results in Acute Myeloid Leukemia Induction
    England, James
    Saini, Lalit
    Hogge, Donna
    Szkotak, Artur J.
    Brandwein, Joseph M.
    Hudoba, Monika
    Medvedev, Nadejda
    Smith, Tyler
    Kristine, Roland
    Sanford, David
    BLOOD, 2017, 130
  • [3] Re-Induction Therapy Decisions Based on Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia
    Morris, Tod A.
    Rizzieri, David A.
    de Castro, Carlos M.
    Diehl, Louis F.
    Gockerman, Jon P.
    Lagoo, Anand S.
    Moore, Joseph O.
    Rao, Arati V.
    BLOOD, 2011, 118 (21) : 1532 - 1533
  • [4] Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia
    Morris, Tod A.
    DeCastro, Carlos M.
    Diehl, Louis F.
    Gockerman, Jon P.
    Lagoo, Anand S.
    Li, Zhiguo
    Moore, Joseph O.
    Rizzieri, David A.
    Rao, Arati V.
    LEUKEMIA RESEARCH, 2013, 37 (01) : 28 - 31
  • [5] Time to Abandon the Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy
    Branham, Zachery Clint
    Okereke, Chijioke
    Shoukier, Mahran
    Bradshaw, Danielle
    Kolhe, Ravindra
    Jillella, Anand P.
    Kota, Vamsi K.
    BLOOD, 2022, 140 : 8929 - 8929
  • [6] Day 14 Bone Marrow Evaluation During Acute Myeloid Leukemia Induction in a Real-world Canadian Cohort
    England, James T.
    Saini, Lalit
    Hogge, Donna
    Forrest, Donna
    Narayanan, Sujaatha
    Power, Maryse
    Nevill, Thomas
    Kuchenbauer, Florian
    Hudoba, Monika
    Szkotak, Artur
    Brandwein, Joseph
    Sanford, David
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (07): : E427 - E436
  • [7] Day 14 bone marrow examination in the management of acute myeloid leukemia
    Terry, Christopher M.
    Shallis, Rory M.
    Estey, Elihu
    Lim, Seah H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : 1079 - 1084
  • [8] Revisiting the Role of Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia
    Jamy, Omer
    Bourne, Garrett
    Mudd, Todd William
    Thigpen, Haley
    Bhatia, Ravi
    CANCERS, 2025, 17 (05)
  • [9] EVALUATION OF BONE MARROW ON DAY 5 OF INDUCTION THERAPY FOR ACUTE MYELOID LEUKEMIA FOR IDENTIFICATION OF CHEMO-RESISTANT BLAST SUBPOPULATIONS
    Ofran, Y.
    Yaari, S.
    Hoffman, R.
    Horowitz, N.
    Hayun, M.
    HAEMATOLOGICA, 2013, 98 : 281 - 281
  • [10] Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3+7" induction regimen for acute myeloid leukemia
    Ofran, Yishai
    Leiba, Ronit
    Ganzel, Chezi
    Saban, Revital
    Gatt, Moshe
    Ram, Ron
    Arad, Ariela
    Bulvik, Shlomo
    Hellmann, Ilana
    Gino-Moor, Sharon
    Zuckerman, Tsila
    Hoffman, Ron
    Horowitz, Netanel
    Lavi, Noa
    Ringelstein, Shimrit
    Henig, Israel
    Hayun, Michal
    Rowe, Jacob M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : 1159 - 1164